John Nuss, the CHIEF SCIENTIFIC OFFICER of $VTYX ($VTYX), sold 21,119 shares of the company on 12-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their shares. Following this trade, they now own 464,582 shares of $VTYX stock.
$VTYX Insider Trading Activity
$VTYX insiders have traded $VTYX stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $VTYX stock by insiders over the last 6 months:
- JOHN NUSS (CHIEF SCIENTIFIC OFFICER) has traded it 2 times. They made 0 purchases and 2 sales, selling 34,280 shares.
- SHEILA GUJRATHI purchased 130,000 shares.
- RAJU MOHAN (CEO AND PRESIDENT) has traded it 2 times. They made 2 purchases, buying 500,000 shares and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VTYX Hedge Fund Activity
We have seen 62 institutional investors add shares of $VTYX stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 5,247,646 shares (-100.0%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 1,303,384 shares (-22.6%) from their portfolio in Q3 2024
- SIO CAPITAL MANAGEMENT, LLC added 1,193,024 shares (+153.2%) to their portfolio in Q3 2024
- OPALEYE MANAGEMENT INC. removed 1,190,000 shares (-100.0%) from their portfolio in Q3 2024
- UBS GROUP AG added 1,175,766 shares (+5438.3%) to their portfolio in Q3 2024
- PARKMAN HEALTHCARE PARTNERS LLC removed 1,160,022 shares (-100.0%) from their portfolio in Q3 2024
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 885,931 shares (+15.2%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
